Bradley L. Campbell, President and CEO: Amicus Therapeutics FOLD Sell · Filed 25/02/21

Trade details

Type: Insider sale
Amount: $4,000
Shares · price: 400 sh · $10.00 a share
Held after: 1,150,657 sh
Stock: Amicus Therapeutics FOLD
Person: Bradley L. CampbellPresident and CEO
Trade date: 25/02/19
Filed: 25/02/21
Days to filing: 2 days

Sold under 0.1% of holdings

Share of holding sold: under 0.1%

Amicus Therapeutics trades, last 26 weeks

What else happened in Amicus Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/20~25/03/21

Bradley L. Campbell's recent trades

Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$322.9K
22,500 sh
$322.9K
Filed 03/04
Traded 03/02
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$1.1M
75,000 sh
$1.1M
Filed 01/22
Traded 01/20
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$846.3K
77,926 sh
$846.3K
Filed 25/12/17
Traded 25/12/15
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$146K
14,587 sh
$146K
Filed 25/12/03
Traded 25/12/01
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$146.5K
14,587 sh
$146.5K
Filed 25/11/26
Traded 25/11/24